Patrick Strangward, M. J. H. (2018). Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria [Immunology and Inflammation]. National Academy of Sciences.
Chicago Style (17th ed.) CitationPatrick Strangward, Michael J. Haley. Targeting the IL33-NLRP3 Axis Improves Therapy for Experimental Cerebral Malaria [Immunology and Inflammation]. National Academy of Sciences, 2018.
MLA (9th ed.) CitationPatrick Strangward, Michael J. Haley. Targeting the IL33-NLRP3 Axis Improves Therapy for Experimental Cerebral Malaria [Immunology and Inflammation]. National Academy of Sciences, 2018.
Warning: These citations may not always be 100% accurate.